DrugBiological
Antilymphocyte Serum clinical trials
Also written ATGAM and Equine Anti-Thymocyte Globulin.
- studies test it
- 156
- open now
- 16
- in phase 3
- 17
- first study started
- 1992
Keep track of what changes. Save the Antilymphocyte Serum studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Studies by the year they started
154 studies that test it; most in 2005 (11); 1 more planned to start later
| Year | Studies |
|---|---|
| 1992 | 1 |
| 1995 | 2 |
| 1997 | 3 |
| 1998 | 4 |
| 1999 | 2 |
| 2000 | 8 |
| 2001 | 2 |
| 2002 | 10 |
| 2003 | 6 |
| 2004 | 5 |
| 2005 | 11 |
| 2006 | 8 |
| 2007 | 11 |
| 2008 | 8 |
| 2009 | 7 |
| 2010 | 5 |
| 2011 | 7 |
| 2012 | 6 |
| 2013 | 5 |
| 2014 | 1 |
| 2015 | 5 |
| 2016 | 4 |
| 2017 | 7 |
| 2018 | 5 |
| 2019 | 3 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 2 |
| 2023 | 4 |
| 2024 | 2 |
| 2025 | 5 |
| 2026 | 3 |
By phase
A phase 1/2 study counts in both.
- Early Phase 1
- 2
- Phase 1
- 28
- Phase 2
- 106
- Phase 3
- 17
- Phase 4
- 10
- No phase
- 12
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 4 · Other 152
Masonic Cancer Center, University of Minnesota (11) · Fred Hutchinson Cancer Center (10) · National Institute of Allergy and Infectious Diseases (NIAID) (8) · Stanford University (8) · National Heart, Lung, and Blood Institute (NHLBI) (6) · M.D. Anderson Cancer Center (5) · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (4) · Memorial Sloan Kettering Cancer Center (4)
Often tested with
Tested in the same studies.
Fludarabine (54) · Cyclophosphamide (49) · Busulfan (35) · Mycophenolic Acid (26) · Cyclosporine (26) · Tacrolimus (25) · Fludarabine phosphate (22) · Melphalan (18)
Studies
Open first, then newest update. How each study uses Antilymphocyte Serum is read from its arms, and is right about nine times in ten.
Testing it · 156
- Conditioning Regimen Containing Low-Dose ATG for the Treatment of AA Receiving sUCBTNot yet recruitingPhase 2Anhui Provincial HospitalNCT07885982Written as Anti-Thymocyte Globulin (Rabbit) (Thymoglobulin®)
- Allogeneic Hematopoietic Stem Cell Transplant for GATA2 MutationsRecruitingPhase 2National Cancer Institute (NCI)NCT01861106Written as Equine Anti-Thymocyte Globulin
- Population PK-guided ATG Dosing for Haploidentical Hematopoietic Stem Cell TransplantationRecruitingPhase 3Daihong LiuNCT07862127Written as Anti-Thymocyte Globulin (ATG)
- Platform Trial to Delay Stage 3 Diabetes: Comparing Teplizumab With ATGRecruitingPhase 2National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NCT07216391Written as Antithymocyte Globulin (ATG)
- Population PK-guided ATG Dosing in Haplo-HSCTRecruitingPhase 2Chinese PLA General HospitalNCT07791576Written as Anti Thymocyte Globulin
- A Study of VABu Conditioning Regimen in Allo-HSCT for AML PatientsNot yet recruitingNot applicableThe First Affiliated Hospital of Soochow UniversityNCT07762508Written as Antithymocyte Globulin (ATG)
- Autologous Stem Cell Transplantation in Patients With Systemic SclerosisRecruitingPhase 2Paul SzabolcsNCT03630211Written as Anti Thymocyte Globulin
- Study of HLA-Haploidentical Stem Cell Transplantation to Treat Clinically Aggressive Sickle Cell DiseaseRecruitingPhase 2University of Illinois at ChicagoNCT03121001Written as ATG
- Methylprednisolone, Horse Anti-Thymocyte Globulin, Cyclosporine, Filgrastim, and/or Pegfilgrastim or Pegfilgrastim Biosimilar in Treating Patients With Aplastic Anemia or Low or Intermediate-Risk Myelodysplastic SyndromeRecruitingPhase 2M.D. Anderson Cancer CenterNCT01624805Written as Anti-Thymocyte Globulin
- Individualized Application of Anti-Thymocyte Globulin(ATG)in Unrelated Donor Hematopoietic Stem Cell TransplantationRecruitingPhase 4Daihong LiuNCT07648992Written as Anti-Thymocyte Globulin
- Haplo-Cord HSCT for AML/MDSRecruitingNot applicableFujian Medical University Union HospitalNCT07588360Written as Fludarabine, Cytarabine, Busulfan, Antithymocyte Globulin (ATG), Melphalan, Cyclophosphamide (CTX)
- Stem Cell Transplantation in Crohn's DiseaseRecruitingPhase 1/2Cedars-Sinai Medical CenterNCT04224558Written as lymphocyte immune globulin
- A Reduced-Intensity Conditioning Regimen (Cyclophosphamide, Pentostatin, Anti-thymocyte Globulin) Followed by Haploidentical Hematopoietic Stem Cell Transplant for the Treatment of Patients With Refractory or Recurrent Severe Aplastic AnemiaRecruitingPhase 1City of Hope Medical CenterNCT05757310Written as Anti-Thymocyte Globulin
- Precision Administration of Anti-thymocyte Globulin With or Without VerapamilRecruitingPhase 2University of FloridaNCT06455319Written as Anti-thymocyte globulin (ATG)
- Phase 1b/2a Trial of Allogeneic HSCT From an HLA-partially Matched Related or Unrelated Donor After TCRab+ T-cell/CD19+ B-cell Depletion for Patients With Monogenic and/or Early-onset Medically Refractory Crohn DiseaseNot yet recruitingPhase 1/2Stanford UniversityNCT06986382Written as ATG
- Allogeneic Hematopoietic Stem Cell Transplantation for 4/M NeuroblastomaNot yet recruitingPhase 2Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityNCT05303727Written as Anti Thymocyte Globulin
- A Trial Comparing Unrelated Donor BMT With IST for Pediatric and Young Adult Patients With Severe Aplastic Anemia (TransIT, BMT CTN 2202)TerminatedPhase 3Boston Children's HospitalNCT05600426Written as horse anti-thymocyte globulin (ATG)
- Treg Modulation With CD28 and IL-6 Receptor AntagonistsCompletedPhase 1/2National Institute of Allergy and Infectious Diseases (NIAID)NCT04066114Written as antithymocyte globulin (rabbit)
- TReatment for ImmUne Mediated PathopHysiologyActive, not recruitingPhase 2National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NCT04862221Written as Equine anti-thymocyte globulin
- T Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation Conditioned With a Reduced Intensity Regimen in Patients With Hematologic Malignancies and Aplastic AnemiaActive, not recruitingPhase 1Memorial Sloan Kettering Cancer CenterNCT03531736Written as Antithymocyte globulin (Rabbit)
See all 156 studies that test Antilymphocyte Serum →
Given in every arm · 76 — Antilymphocyte Serum is usual care beside what is tested
- Advancing Transplantation Outcomes in ChildrenRecruitingPhase 2National Institute of Allergy and Infectious Diseases (NIAID)NCT06055608Written as Anti-Thymocyte Globulin (ATG)
- Sirolimus+Ruxolitinib+Mycophenolate Mofetil for Prophylaxis of aGVHD in Patients Receiving Haplo-HSCT Who Are Intolerant to CNINot yet recruitingPhase 1/2Peking University People's HospitalNCT07796620Written as ATG
- Personalized NK Cell Therapy in CBTRecruitingPhase 2M.D. Anderson Cancer CenterNCT02727803Written as Anti-Thymocyte Globulin
- Study Comparing the Efficacy of 2 RIC Regimens (Clofarabine vs Fludarabine) in Adults With AML Eligible to Allo-SCTRecruitingPhase 2Nantes University HospitalNCT05917405Written as ATG
- Study Testing Two Conditioning Regimen With a Single Prophylaxis of GVHD by Cyclophosphamide and Methotrexate Post-transplant in Patients Eligible for Matched-donor Allograft TransplantationRecruitingPhase 2Nantes University HospitalNCT06252870Written as Anti-Thymoglobulin
- Autologous Stem Cell Transplantation for Crohn's DiseaseRecruitingPhase 1/2Paul SzabolcsNCT00692939Written as ATG
- Sirolimus+Abatacept+Mycophenolate Mofetil for Prophylaxis of aGVHD in Patients Receiving Haplo-HSCT Who Are Intolerant to Calcineurin InhibitorsNot yet recruitingPhase 1/2Peking University People's HospitalNCT06279494Written as ATG
- Early Trial of Allogeneic Hematopoietic Stem Cell Transplantation for Patients Who Will Receive a Kidney Transplant From the Same DonorRecruitingPhase 1/2Alice BertainaNCT05508009Written as ATG
- Outcomes of Patients After Allo-HSCT With Decitabine and NACNot yet recruitingPhase 3The First Affiliated Hospital of Soochow UniversityNCT04945096Written as Anti-thymocyte globulin
- Giving Chemotherapy for a Shortened Amount of Time Before a Stem Cell TransplantationActive, not recruitingPhase 1Memorial Sloan Kettering Cancer CenterNCT04098393Written as Antithymocyte globulin (ATG)
- Study of Intensity Modulated Total Marrow Irradiation (IM-TMI) in Addition to Fludarabine/Busulfan Conditioning for Allogeneic Transplantation in High Risk AML and Myelodysplastic SyndromesActive, not recruitingPhase 2University of Illinois at ChicagoNCT03121014Written as ATG
- BIVV020 (SAR445088) in Prevention and Treatment of Antibody-mediated Rejection (AMR)Active, not recruitingPhase 2SanofiNCT05156710Written as Antithymocyte globulin (ATG)
- Cytokine-Treated Veto Cells in Treating Patients With Hematologic Malignancies Following Stem Cell TransplantActive, not recruitingPhase 1/2M.D. Anderson Cancer CenterNCT03622788Written as Anti-Thymocyte Globulin
- hATG+CsA vs hATG+CsA+Eltrombopag for SAACompletedPhase 3European Society for Blood and Marrow TransplantationNCT02099747Written as hATG
- UCB Transplant for Hematological Diseases Using a Non Myeloablative PrepCompletedPhase 2Masonic Cancer Center, University of MinnesotaNCT02722668Written as ATG
- ATG Plus Low-dose PT-Cy for GVHD PreventionTerminatedPhase 3Peking University People's HospitalNCT06108739Written as ATG
- Hematopoietic Stem Cell Transplant for Dyskeratosis Congenita or Severe Aplastic AnemiaCompletedNot applicableMasonic Cancer Center, University of MinnesotaNCT02162420Written as Anti-thymocyte globulin
- Gemcitabine Hydrochloride, Clofarabine, and Busulfan Before Donor Stem Cell Transplant in Treating Patients With Refractory B-Cell or T-Cell Non-Hodgkin Lymphoma or Hodgkin LymphomaCompletedPhase 1/2M.D. Anderson Cancer CenterNCT01701986Written as Anti-Thymocyte Globulin
- CMC-544 and Allogeneic Transplantation for CD22 Positive-Lymphoid MalignanciesCompletedPhase 1/2M.D. Anderson Cancer CenterNCT01664910Written as Anti-Thymocyte Globulin
- Busulfan, Cyclophosphamide, & Antithymocyte Globulin Followed by Stem Cell Transplant in Treating Hematologic CancerCompletedPhase 2University of NebraskaNCT00611351Written as anti-thymocyte globulin
Showing 20 of 76.
As the comparator · 14 — what is tested is compared with Antilymphocyte Serum
- GVHD Prophylaxis by Addition of CD20 Monoclonal Antibody to the Conditioning Regimen in SAA With Treatment of Allo-HSCTRecruitingPhase 2The First Affiliated Hospital of Soochow UniversityNCT05510505Written as ATG
- Post Transplant Cyclophosphamide in Matched Unrelated Donor Stem Cell Transplantation for Hematological MalignanciesRecruitingPhase 2/3Hospital Israelita Albert EinsteinNCT03818334Written as ATG
- GvHD Prophylaxis in Unrelated Donor HCT: Randomized Trial Comparing PTCY Versus ATGActive, not recruitingPhase 3DKMS gemeinnützige GmbHNCT05153226Written as ATG
- A Study of TCD601 in de Novo Renal Transplant RecipientsCompletedPhase 2ITB-Med LLCNCT05669001Written as ATG
- A Dose Escalation Study of TCD601 Compared to ATG in de Novo Renal TransplantationTerminatedPhase 2ITB-Med LLCNCT06365437Written as ATG
- Targeted Dose Study of ATG in Haploidentical Hematopoietic Stem Cell TransplantationCompletedPhase 3Chinese PLA General HospitalNCT05166967Written as Antithymocyte globulin
- A Dose Escalation Study in de Novo Renal TransplantationCompletedPhase 2ITB-Med LLCNCT04311632Written as ATG
- ATG/PTCy in Haplo-PBSCT Randomized Controlled,Multi-centerCompletedPhase 4Shanghai General Hospital, Shanghai Jiao Tong University School of MedicineNCT03608059Written as standard ATG
- M-PTCy vs BuCy in Haploidentical HSCT for Acute LeukemiaStatus unknownPhase 2/3The First Affiliated Hospital of Soochow UniversityNCT05739630Written as ATG
- Clinical Study of rATG Individualized Administration in Haploidentical Hematopoietic Stem Cell TransplantationStatus unknownPhase 4The First Affiliated Hospital of Soochow UniversityNCT05634915Written as ATG
- Cyclophosphamide Versus Anti-thymocyte Globulin for GVHD Prophylaxis After RIC Allo-SCTCompletedPhase 2Assistance Publique - Hôpitaux de ParisNCT02876679Written as Anti-Thymocyte Globulin
- Observational Study to Evaluate the Safety and Efficacy of Polyclonal Antibodies in Simultaneous Pancreas Kidney Transplant RecipientsStatus unknownPhase 4Tianjin First Central HospitalNCT03470961Written as Anti-Thymocyte Globulins
- Visilizumab for the Prevention of Graft-versus-Host Disease After Allogeneic Hematopoietic Cell TransplantationTerminatedPhase 2H. Lee Moffitt Cancer Center and Research InstituteNCT00720629Written as Antithymocyte globulin (ATG)
- Evaluating Safety and Efficacy of TOL101 Induction Versus Anti-Thymocyte Globulin to Prevent Kidney Transplant RejectionStatus unknownPhase 1/2Tolera Therapeutics, IncNCT01154387Written as Anti-Thymocyte Globulin
Codes
What other systems call Antilymphocyte Serum · ClinicalTrials.gg INT007004
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D000961 | Antilymphocyte Serum | One source ClinicalTrials.gov |
| RxNorm | 973 | — | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.